Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
Clinical trial NCT07767630 · RECRUITING
Trial details
- NCT number
- NCT07767630
- Sponsor
- Sichuan University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2027-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.